Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Stem Cell Research|October 31, 2025
Generation of iPSCs (RFSCi007-A, RFSCi008-A) from a patient with early-onset bilateral drusen and a healthy sibling for retinal disease modelingSonali Singh, Wendy Runyon, Sam Hu, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 31, 2013
Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyesElad Moisseiev, Michael Waisbourd, Elad Ben-Artsi, et al.
Journal of Proteome Research|October 7, 2006
Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donorsEunkyung An, Xiaoning Lu, Jessica Flippin, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 15, 2026
US Retina Specialists' Preferences for Geographic Atrophy TreatmentKarl Csaky, Anthony M Pepio, Caitlin Thomas, et al.
Ophthalmology|June 23, 2024
Phase 1 Study of JNJ-81201887 Gene Therapy in Geographic Atrophy Secondary to Age-Related Macular DegenerationJeffrey S Heier, Michael N Cohen, Daniel L Chao, et al.
Ophthalmology|November 24, 2024
Visual Loss in Geographic Atrophy: Learnings from the Lampalizumab TrialsNeha Anegondi, Verena Steffen, Srinivas R Sadda, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 14, 2007
Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosisWai T Wong, Elvira Agrón, Hanna R Coleman, et al.
Ophthalmology|March 26, 2013
Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophyLorah T Perlee, Aruna T Bansal, Karen Gehrs, et al.
Retina (Philadelphia, Pa.)|March 2, 2022
INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: Phase 2 RUBY Randomized TrialDavid M Brown, David S Boyer, Karl Csaky, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized TrialJeffrey S Heier, Allen C Ho, David S Boyer, et al.
Pageof 3